Format

Send to

Choose Destination
Ann Indian Acad Neurol. 2019 Apr-Jun;22(2):131-136. doi: 10.4103/aian.AIAN_345_18.

Can We Treat Secondary Progressive Multiple Sclerosis Now?

Author information

1
Department of Neurology, All India Institute of Medical Sciences, New Delhi, India.

Abstract

Secondary progressive multiple sclerosis (SPMS) is characterized by progressive accumulation of disability without intermittent recovery. Treatment of these patients is challenging due to limited understanding of pathogenesis and fewer therapeutic options. This article summarizes difficulties in defining and conducting trials in SPMS, review major clinical trials on therapies approved and unapproved in SPMS and lastly, therapies in pipeline for use in SPMS.

KEYWORDS:

Disease modifying therapy; Secondary progressive MS; mitoxantrone; progressive MS

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd Icon for PubMed Central
Loading ...
Support Center